Skip to main content

Peer Review reports

From: Combination of an autophagy inhibitor with immunoadjuvants and an anti-PD-L1 antibody in multifunctional nanoparticles for enhanced breast cancer immunotherapy

Original Submission
30 May 2022 Submitted Original manuscript
22 Jun 2022 Reviewed Reviewer Report
23 Jun 2022 Reviewed Reviewer Report
25 Jun 2022 Reviewed Reviewer Report
26 Jun 2022 Reviewed Reviewer Report
24 Jul 2022 Author responded Author comments - Yibin Cheng
Resubmission - Version 2
24 Jul 2022 Submitted Manuscript version 2
28 Jul 2022 Reviewed Reviewer Report
29 Jul 2022 Reviewed Reviewer Report
1 Aug 2022 Reviewed Reviewer Report
19 Sep 2022 Author responded Author comments - Yibin Cheng
Resubmission - Version 3
19 Sep 2022 Submitted Manuscript version 3
11 Oct 2022 Reviewed Reviewer Report
15 Oct 2022 Author responded Author comments - Yibin Cheng
Resubmission - Version 4
15 Oct 2022 Submitted Manuscript version 4
Publishing
17 Oct 2022 Editorially accepted
28 Oct 2022 Article published 10.1186/s12916-022-02614-8

You can find further information about peer review here.

Back to article page